Avanços na distinção entre cancros da próstata agressivos e os não agressivos

Uns "tratam-se" (e deixam muitas pessoas incontinentes ou impotentes) outros "deixam-se andar". Por isso convém saber quais são quais:
http://www.express.co.uk/life-style/health/773513/prostate-cancer-symptoms-test-treatment-UK

Citando:
"Professor Vincent Moulton, co-author on the study said experts are trying to group cancers which show common traits in a bid to improve classification of tumours.

"These were categorised by low expression of a core set of 45 genes, many encoding proteins involved in the structure of cells, transport of ions (charged molecules) and cell adhesion,” he said.

“This was common across the samples of cancers known to have a poor patient prognosis."

The research is reported in the journal European Urology Focus."

Diagnóstico de AVCs em segundos com equipamento portátil

Scientists could diagnose strokes in seconds with world's first portable brain scanner - Mirror Online

IBM desenvolve laboratório miniaturizado para diagnósticos médicos

http://eandt.theiet.org/news/2016/aug/ibm-lab-on-chip-medical-diagnosis.cfm


Citando:
"Lab-on-a-chip technologies have become an incredibly helpful diagnostic tool for physicians as they can be significantly faster, portable, easy to use and require less sample volume to help detect diseases.
IBM hopes to eventually shrink the devices down to a single silicon chip that carries all of the processes necessary to analyse a disease that would normally be carried out in a full-scale biochemistry lab.
Its current device is roughly 2cm by 2cm and it is continuing development to increase the device density to improve its functionality."


(...)
"The IBM team targeted exosomes with their device as existing technologies face challenges for separating and purifying exosomes in liquid biopsies.
They range in size from 20-140nm and contain information about the health of the originating cell that they are shed from. Determining the size, surface proteins and nucleic acid cargo carried by exosomes can give essential information about the presence and state of developing cancer and other diseases."

Microsoft usa dados de pesquisa para antecipar diagnóstico de Cancro Pancreático

https://www.washingtonpost.com/news/innovations/wp/2016/06/10/what-happens-when-your-search-engine-is-first-to-know-you-have-cancer/


Citando:
"The Microsoft researchers identified Web users who had recently searched for queries indicating they have pancreatic cancer, such as “I was told I have pancreatic cancer, what to expect,” and then looked back months earlier to examine patterns in the symptoms that the users searched for. This included phrases such as “dark or tarry stool,” “abdominal swelling,” “dark urine” and “yellowing skin.”
From this analysis they realized trends in the queries of users who were soon to be diagnosed with pancreatic cancer, identifying 5 to 15 percent of cases with low false-positive rates. The research was published in the Journal of Oncology Practice."